|
Post by porkini on May 1, 2021 19:02:07 GMT -5
So when I go to DMV and take a number to be served, I can sell my ticket and make some $ while I'm getting my license. I didn't know that. Thanks for educating me in our wonderful system. As long as you find a willing buyer at a price you both agree upon...
|
|
|
Post by olebob1 on May 1, 2021 20:08:00 GMT -5
I want to ask Mike about UTHR spending $105 million to accurate review of Tyvaso DPI through FDA. Is that a bribe to FDA? WTF, if drugs are good enough for reviews why FDA charging that amount for place the drug in front of the line for reviews? Is it a bribe? Surely you jest! I hope you are just having a little fun.
|
|
|
Post by olebob1 on May 1, 2021 20:21:18 GMT -5
Drug Makers Buy Pricey Vouchers to Speed Products to Market Nov. 1, 2015 7:40 pm ET AbbVie, Sanofi are among those paying large sums for ‘priority review’ at FD There is a new price surge in the pharmaceutical industry—not for medications, instead for a limited number of government-issued vouchers that drug makers, including AbbVie Inc. and Sanofi SA, are buying to speed products to market. Legal provisions enacted in 2007 and 2012 require the U.S. Food and Drug Administration to issue “priority review vouchers” as rewards to developers of drugs for rare pediatric conditions or tropical diseases, such as malaria. Congress intended the vouchers to encourage more research into underfunded diseases. Companies receive them when the FDA approves their drug for sale and can redeem them to speed FDA consideration of a subsequent drug for any disease. The vouchers require the FDA to shorten its decision deadline to six months from the standard 10 months—potentially giving companies an extra four months’ worth of sales. The voucher doesn’t guarantee the FDA will approve the drug. Because companies can also sell the vouchers, a lucrative secondary market has emerged. AbbVie agreed in August to pay $350 million for a voucher from United Therapeutics Corp. , which received it for developing a pediatric cancer treatment. Nice summation! Thank you for the clarification. Seems expensive to gain a few months, but Martine appears to know what she it doing. Best wishes to UTHR, get it done in a hurry!
|
|
|
Post by olebob1 on May 1, 2021 20:23:41 GMT -5
So when I go to DMV and take a number to be served, I can sell my ticket and make some $ while I'm getting my license. I didn't know that. Thanks for educating me in our wonderful system. As long as you find a willing buyer at a price you both agree upon... What a novel idea. What shall we call it.
|
|
|
Post by wyattdog on May 1, 2021 21:08:03 GMT -5
I Made $180 Simply Waiting in Line at the DMV By Michael Pruser · Updated: March 10, 2021 How to Make Money at the DMV
I took a quick scan of the DMV and noticed mostly somber people. Some were on their cell phones, others were just staring into space and knowing the feeling I have sometimes when I have a two hour wait ahead of me, I decided to take action. When D-655 was called, I had about five minutes to sell (and trade) my spot in line. A few things crossed my mind when I decided to do this:
Would I be asked to leave the DMV? Is what I’ve chosen to do somehow breaking the law or ethically wrong? I thought if I was someone else at the DMV, would I be affected in any way by someone selling their spot in line. The answer was no to all questions. Would I have the stones to do this? To get maximum value, I’d have to stand up where everyone could see me and announce that I was next in line, and anyone that wanted to buy that spot (and give me their ticket as well) could pay me cash to do so. Never been too afraid of public speaking, so this wasn’t a problem either.
So, I put my laptop down on the ground, stood on top of my chair and said loudly
“I have ticket D-657. If anyone wants to be trade their ticket with me for a little coin, come on over before they call my number”. had the attention of the room and even the DMV workers helping others looked at me. For a few seconds, I saw only blank stares and smiles; and then I had a heavy set fellow walk over to me with ticket D-680 and a $20 bill. I looked around to see if there was any other interest; and we swapped. I said thank you, he was called up in a couple of minutes and I sat back down knowing in about an hour, I would do the whole thing again.
Truth be told I had a lot of tension leading up to the first ticket sale. As I did this a few times more, it got easier and easier. I would simply sit in my chair waiting for my number to approach and repeat the auction process with a new group of tired DMV patrons. After the second time, I took my new number and left the DMV for 45 minutes (Burger King down the road) and returned in plenty of time.
The whole day just flew by and before I knew it, I had traded my number for a 6th time, and had amassed a total of $180. (The best trade being a $50 one). With only about an hour left before the DMV closed, I decided to simply wait out my turn in line, get my vehicle registered and call it a day.
My registration costs were $130, so when I left the DMV, I was one Ulysses S. Grant richer with a “free” registration. Not only that, I was able to tackle a good amount of work while just waiting my turn so it’s not as if I have to factor in “opportunity cost” to my revenues at the DMV. I had fun, I made money, and I was able to knock out one of the most annoying errands anyone has to accomplish.
|
|
|
Post by uvula on May 1, 2021 21:15:34 GMT -5
Capitalism at its finest. You don't actually need to conduct business with the DMV in order to get in line. If you're unemployed or have nothing to do, you can get in line every day.
|
|
|
Post by bones1026 on May 1, 2021 22:10:26 GMT -5
And therefore any scripts written by Vdex providers and filled by Eagle would not show up in the Symphony numbers. But what you can do is use the Symphony numbers as a guide and allow for a discount to cover the Eagle numbers. That is what I do, but if the Eagle numbers are increasing rapidly as a percentage of sales then that discount will lead to an underestimate. So not an investor, but monitor and track script counts? I’m missing something.
|
|
|
Post by mytakeonit on May 1, 2021 22:17:21 GMT -5
In Hawaii to do a vehicle reregistration online, you just need the info required on the form ... like vehicle make, model, year, Vehicle ID number, insurance info, and maybe a few more things. You can pay using a credit card.
If it's a new vehicle, usually the auto dealer will have done all the work for you. It may take several hours depending on the time of day and how busy the vehicle registration department is. The dealer will have someone drive you home and pick you up when the car is ready.
But, that's mytakeonit
|
|
|
Post by agedhippie on May 2, 2021 8:31:38 GMT -5
But what you can do is use the Symphony numbers as a guide and allow for a discount to cover the Eagle numbers. That is what I do, but if the Eagle numbers are increasing rapidly as a percentage of sales then that discount will lead to an underestimate. So not an investor, but monitor and track script counts? I’m missing something. Curiosity. Are only investors allowed to track the scripts?
|
|
|
Post by longliner on May 2, 2021 11:02:53 GMT -5
So not an investor, but monitor and track script counts? I’m missing something. Curiosity. Are only investors allowed to track the scripts? It's just a fun hobby amongst finance professionals. 🤣😏
|
|
|
Post by cretin11 on May 2, 2021 11:31:01 GMT -5
So not an investor, but monitor and track script counts? I’m missing something. Curiosity. Are only investors allowed to track the scripts? Cmon aged, spill it man, what are you REALLY up to? 😆🤔🙀👁👀
|
|
|
Post by henry on May 2, 2021 13:21:18 GMT -5
If the sped up approval process is just as safe for users then why isn't it used at no extra cost for all new drugs. Haven't those who might have benefited from the drug who suffered or died without it paid the price for the slower process? And if it is not as safe as the longer process then the adverse effects will have come at the cost of the government being bought off. What is the purpose of the FDA? To serve the public or to make money for the government?
|
|
|
Post by mymann on May 2, 2021 13:48:15 GMT -5
It was a rhetorical question out of frustration towards FDA. I was holding a gruge because of the process mnkd had to go through to get Afrezza approved.
|
|
|
Post by mymann on May 2, 2021 13:52:57 GMT -5
The real question I want answered is why the delay in pediatric study? The money raised recently should be used for the study unless there is another reason?
|
|
|
Post by stevil on May 2, 2021 14:29:27 GMT -5
While not privy to "the process" the FDA employs, I'd imagine the length of time and the ability to cut in line has more to do with a backlog due to limited resources.
There are only so many people at the FDA who can spend X amount of hours in a day reviewing information to approve or deny therapies. The way this process was hastened was by removing certain regulations that were viewed as unnecessary, thus decreasing the number of boxes that needed to be checked in order to get approved. Then, if someone wants to jump the line for priority review, they can pay another company to swap places with them in line. I don't believe the FDA was paid the money for priority review. I believe whichever company traded places with UTHR received the cash.
The MVD analogy was actually quite good if you need to see how this plays out.
|
|